What’s going on with Trump’s cuts to PrEP funding?

The president’s freeze on foreign aid has raised many questions about HIV/AIDS prevention and treatment in the U.S. and abroad

Wait, did Trump just cut PrEP funding for queer and trans people? And if you are an American on PrEP, is your prescription at risk?

In January, U.S. President Donald Trump and Secretary of State Marco Rubio ordered a 90-day freeze on foreign aid. That freeze included the President’s Emergency Plan for AIDS Relief (PEPFAR), which is a program that provides HIV testing and medication around the world. As of September 2024, PEPFAR supported life-saving antiretroviral therapy for 20.6 million people, including 566,000 children living with HIV.

But a subsequent memo from Rubio has raised concerns about the Trump administration’s funding for PrEP overall. A document from Rubio about the foreign aid freeze specifically stated that anything having to do with “gender or DEI ideology programs” and “transgender surgeries” would not be funded while another document mentioned that PEPFAR-funded PrEP would only be given to pregnant and breastfeeding women.

While currently the foreign aid freeze has no effect on domestic PrEP prescriptions, the effects of this funding freeze have already been devastating. The Joint United Nations Programme on HIV/AIDS estimates that there have been thousands of new HIV infections worldwide in just the first two weeks since the funding freeze was introduced. 

Senior editor Mel Woods breaks down what you need to know. 

Senior editor Mel Woods is an English-speaking Vancouver-based writer, editor and audio producer and a former associate editor with HuffPost Canada. A proud prairie queer and ranch dressing expert, their work has also appeared in Vice, Slate, the Tyee, the CBC, the Globe and Mail and the Walrus.

Keep Reading

Renée Richards at a tennis match

The complicated legacy of Renée Richards

The former tennis player broke barriers for trans athletes in 1977. Then she changed her tune
Supporters of HIV AIDS research participate in the 2025 Toronto Pride Parade

Toronto man set to be the first Canadian cured of HIV

The patient received a stem cell transplant for his cancer that acted as a “double cure” because it contained a rare genetic mutation resistant to HIV
A photo of the outside of the New York Times building in New York City

Only 1 in 5 ‘New York Times’ news stories about trans issues quote actual trans people: report

A new 'Assigned Media' report found that the 'New York Times' rarely cited trans people in coverage about trans issues
A side by side of images from On Our Backs, a lesbian magazine.

The radical legacy of ‘On Our Backs’ magazine

“On Our Backs” filled a void by authentically documenting—and celebrating—lesbian sexuality
Advertisement